Bharat Rasayan Ltd (BHARATRAS)

Chemicals · Agro Chemicals · NSE · Updated 2 September 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹1,233.35 ↓ 51.26% (1Y)

🎯 Key Takeaways

Bharat Rasayan Ltd is in a mature cash cow phase with signs of strategic restructuring, characterized by stable promoter control, consistent profitability, and a shift toward capital allocation discipline. Despite a 1Y return of -50.
Revenue grew 9.8% QoQ to ₹338 in Q1FY27.
⚠️ Margin pressure persists despite revenue growth, with OPM declining from 17.7% in June 2025 to 12.9% in June 2026, raising concerns about pricing powe

Market Cap

₹2,050

P/E Ratio

9.0

P/B Ratio

1.81

ROE

12.7%

ROCE

15.9%

Debt/Equity

0.08

Div Yield

0.04%

Promoter

75.0%

✨ Ask AI About BHARATRAS 📊 Interactive Charts

📖 The Story

Bharat Rasayan Ltd is in a mature cash cow phase with signs of strategic restructuring, characterized by stable promoter control, consistent profitability, and a shift toward capital allocation discipline. Despite a 1Y return of -50.28%, the company maintains strong ROE and ROCE, indicating enduring operational efficiency. Management is advancing a corporate restructuring involving BRL Finlease and Centum Finance, signaling a potential simplification or optimization of group entities. The business remains cash-generative, with a focus on sustaining shareholder returns amid a challenging macro backdrop.

📰 What's Happening

In Q1 FY2026, the board approved unaudited standalone financial results showing revenue of ₹3,438 million and declared a final dividend of ₹0.50 per share, payable after the September 2026 AGM, with record date set for September 17. The board also approved in-principle a corporate restructuring involving BRL Finlease and Centum Finance, authorizing further evaluation. SEBI granted MPG Family Trust exemption from open offer requirements twice in August 2026 — first for a 6.9771% stake acquisition via gift from promoter Mahabir Prasad Gupta, and later for a similar 6.98% acquisition — both framed as part of family succession planning. These transactions, valid for one year with compliance conditions, allow private share transfers without triggering public open offer obligations, preserving promoter control and public float stability.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	377	286	270	308	338
Operating Profit	67	27	36	43	44
OPM %	17.7%	9.3%	13.3%	14.1%	12.9%
Net Profit	40	28	40	38	37
EPS	₹95.44	₹67.10	₹24.08	₹22.95	₹22.40

The company's quarterly revenue has shown sequential growth from ₹270 million in December 2025 to ₹338 million in June 2026, indicating an upward trend in top-line performance. However, operating performance has been volatile, with operating margins declining from a peak of 17.7% in June 2025 to 12.9% in June 2026, suggesting margin pressure despite revenue gains. Net profit has remained relatively stable in the short term but declined from ₹40 million in December 2025 to ₹37 million in June 2026, while EPS has trended downward from ₹95.44 in June 2025 to ₹22.4 in June 2026, reflecting potential share issuance or valuation effects. These trends align with management's focus on operational efficiency, though margin compression warrants monitoring in the context of their restructuring rationale.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue, margins, or capital allocation beyond the board-approved restructuring proposal and dividend policy. The declaration of a final dividend of ₹0.50 per share and fixation of the September 17, 2026 record date underscore a commitment to shareholder returns. The corporate restructuring is currently at the in-principle stage, with authorization given for further evaluation — no timeline or specifics on execution have been disclosed. Management's actions suggest a focus on optimizing the corporate structure and maintaining capital efficiency, but strategic clarity remains limited until detailed plans are communicated.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item	Mar 2025	Mar 2025	Mar 2026	Mar 2026
Equity Capital	4	4	4	8
Reserves	1,060	1,126	1,193	1,266
Borrowings	63	85	90	1
Total Liabilities	1,294	1,408	1,456	1,433
Fixed Assets	234	230	223	246
Investments	186	298	298	324
Total Assets	1,294	1,408	1,456	1,433

The balance sheet reflects a strong equity base with minimal debt, as total borrowings remain negligible at ₹90 million as of March 2026, down from ₹85 million in March 2025. Equity has grown steadily from ₹4 million to ₹8 million (face value), supported by reserves of over ₹1,200 million, indicating long-term capital accumulation. Total assets have remained relatively stable around ₹1,430–1,456 million, suggesting a conservative capital structure. The company is not pursuing aggressive expansion or deleveraging, instead maintaining financial flexibility. This supports a strategy of returning capital via dividends rather than reinvesting heavily in growth, consistent with its mature business profile.

💰 Cash Flow Statement (₹ Cr)

Item	Mar 2025
Operating	+172
Investing	-157
Financing	-1
Net Cash Flow	+23

👥 Shareholding Pattern

Category	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Promoters	75.0%	75.0%	75.0%	75.0%
FII	0.5%	0.4%	0.5%	0.4%
DII	2.4%	2.5%	2.1%	2.0%
Public	11.3%	10.6%	10.8%	11.4%
# Shareholders	15,388	21,333	21,935	22,445

Promoter holding remains stable at 74.99% across all recent quarters, indicating no dilution or strategic stake sales. Foreign institutional holdings have fluctuated slightly but remain very low, rising from 0.41% in Q1FY27 to 0.54% in Q4FY26, while domestic institutional ownership has increased from 1.99% to 2.52% over the same period, suggesting modest DII accumulation. The number of public shareholders has grown from 15,388 to 22,445, reflecting retail investor engagement. No pledging or significant share sales by insiders have been reported, and recent SEBI exemptions for family trust acquisitions reinforce continuity in ownership. This stability supports long-term control and investor confidence.

⚖️ Peer Comparison — Agro Chemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
UPL	47,750	23.4	11.4%	6.7%	0.64
PIIND	36,230	31.1	13.3%	10.4%	0.02
SUMICHEM	25,674	44.3	23.1%	17.1%	0.00
BAYERCROP	17,940	371.7	3.3%	1.2%	0.00
SHARDACROP	7,113	11.4	25.8%	20.0%	0.00
DHANUKA	4,409	15.1	27.5%	21.2%	0.03
RALLIS	4,032	24.6	12.9%	9.7%	0.03
NACLIND	3,948	337.1	6.0%	1.8%	0.44
BHAGCHEM	3,496	127.2	6.1%	3.9%	0.33
GSPCROP	2,890	25.3	22.5%	21.9%	0.66

🔗 Peer Stock Analyses

UPL PIIND SUMICHEM BAYERCROP SHARDACROP

⚠️ Risk Factors

1. Margin pressure persists despite revenue growth, with OPM declining from 17.7% in June 2025 to 12.9% in June 2026, raising concerns about pricing power or cost management. 2. The company's heavy reliance on promoter-controlled structure exposes it to governance risks, especially given past related-party transactions and family-led restructuring. 3. Low institutional coverage and thin trading volumes could lead to high volatility and limited liquidity, particularly given the 1Y return of -50.28%. 4. The unresolved corporate restructuring lacks a clear timeline or value creation rationale, leaving investors without visibility on execution or financial impact.

📋 Recent Filings

🧠 Analyst's Read

Bharat Rasayan remains a cash-generative, promoter-dominated business with stable returns and disciplined capital allocation, but its near-term outlook is constrained by margin compression and limited strategic transparency. Investors should monitor the progress of the proposed restructuring and any improvement in operating margins, as these will be critical to sustaining performance and shareholder confidence in the absence of growth catalysts.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on BHARATRAS

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when BHARATRAS files new disclosures

Track BHARATRAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track BHARATRAS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd